FILGRASTIM/AE - Search Results

Year	Number of Results
2014	2
2015	17
2016	13
2017	24
2018	30
2019	26
2020	19
2021	20
2022	14
2023	3

1

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).

Miller DS, Filiaci VL, Mannel RS, Cohn DE, Matsumoto T, Tewari KS, DiSilvestro P, Pearl ML, Argenta PA, Powell MA, Zweizig SL, Warshal DP, Hanjani P, Carney ME, Huang H, Cella D, Zaino R, Fleming GF. Miller DS, et al. J Clin Oncol. 2020 Nov 20;38(33):3841-3850. doi: 10.1200/JCO.20.01076. Epub 2020 Sep 29. J Clin Oncol. 2020. PMID: 33078978 Free PMC article. Clinical Trial.

2

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology. Smith TJ, et al. J Clin Oncol. 2015 Oct 1;33(28):3199-212. doi: 10.1200/JCO.2015.62.3488. Epub 2015 Jul 13. J Clin Oncol. 2015. PMID: 26169616 Review.

3

Filgrastim induced thrombocytopenia.

Kango G, Haroun F. Kango G, et al. BMJ Case Rep. 2020 Jun 30;13(6):e234584. doi: 10.1136/bcr-2020-234584. BMJ Case Rep. 2020. PMID: 32606115 Free PMC article.

4

Filgrastim associations with CAR T-cell therapy.

Gaut D, Tang K, Sim MS, Duong T, Young P, Sasine J. Gaut D, et al. Int J Cancer. 2021 Mar 1;148(5):1192-1196. doi: 10.1002/ijc.33356. Epub 2020 Nov 6. Int J Cancer. 2021. PMID: 33091961 Free PMC article.

5

The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials.

Wang L, Baser O, Kutikova L, Page JH, Barron R. Wang L, et al. Support Care Cancer. 2015 Nov;23(11):3131-40. doi: 10.1007/s00520-015-2686-9. Epub 2015 Mar 29. Support Care Cancer. 2015. PMID: 25821144 Free PMC article. Review.

6

Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma.

Shimano R, Yamamoto H, Nasu I, Kashiwamura Y, Yamamoto G, Uchida N, Taniguchi S, Hayashi M, Ito T. Shimano R, et al. Int J Hematol. 2022 Dec;116(6):856-862. doi: 10.1007/s12185-022-03438-1. Epub 2022 Aug 17. Int J Hematol. 2022. PMID: 35976562

7

Filgrastim for the treatment of hematopoietic acute radiation syndrome.

Farese AM, MacVittie TJ. Farese AM, et al. Drugs Today (Barc). 2015 Sep;51(9):537-48. doi: 10.1358/dot.2015.51.9.2386730. Drugs Today (Barc). 2015. PMID: 26488033 Review.

8

Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis.

Faucon AL, Cereja S, Mussini C, Goujon JM, Caudwell V. Faucon AL, et al. J Nephrol. 2022 May;35(4):1265-1270. doi: 10.1007/s40620-022-01278-0. Epub 2022 Feb 24. J Nephrol. 2022. PMID: 35201596 No abstract available.

9

LA-EP2006: A Pegfilgrastim Biosimilar.

Hoy SM. Hoy SM. BioDrugs. 2019 Apr;33(2):229-232. doi: 10.1007/s40259-019-00348-3. BioDrugs. 2019. PMID: 30887256 Review.

10

Filgrastim, a Recombinant Form of Granulocyte Colony-stimulating Factor, Ameliorates 3-nitropropionic Acid and Haloperidol-induced Striatal Neurotoxicity in Rats.

Rahi V, Ram P, Kumar P. Rahi V, et al. Neurotox Res. 2022 Dec;40(6):2089-2102. doi: 10.1007/s12640-022-00604-5. Epub 2022 Nov 17. Neurotox Res. 2022. PMID: 36385437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results